Pharmaceutical Executive Daily: Johnson & Johnson Separating Its Orthopedics Unit | PharmExec

Johnson & Johnson to Separate Orthopedics Unit

Johnson & Johnson has announced plans to separate its orthopedics business into an independent company.

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry.

In corporate restructuring news, this move is part of the company's strategy.

Johnson & Johnson’s plan to separate its orthopedics division into a standalone company

Author's summary: Johnson & Johnson separates orthopedics unit.

more

PharmExec PharmExec — 2025-10-16